Avery developed osteoporosis after taking Ozempic for about a year without a doctor's supervision. She originally sought the ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Novo Nordisk (NYSE: NVO) has long been a high-quality pharmaceutical company with a focus on diabetes, producing consistent financial results and investor returns. But its stock p ...

Aston Martin’s all new Valkyrie LMH contender has been given a starting weight of 1042 kg for its race debut, making it the ...

MrBeast - whose real name is Jimmy Donaldson - has opened up about his health condition in a new episode of Steven Bartlett's ...

Revenue is growing at double-digit rates, fueled by surging demand for Botox, lip fillers and weight-loss drugs.

OpenAI's for-profit plan is confusing. Here we try to break down what it might mean for the company and its mission of ...

"I've been having pain and UTI issues since I was eight or nine. That's how long I was gaslit into believing my searing pain was 'nothing.'" ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

President Trump is seeking to distance himself from a rise in inflation, arguing the uptick had “nothing to do” with his ...

Three key House moderates told The Hill on Wednesday that they are still not on board with the chamber’s budget resolution, ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.